Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-23-036275

Director acquired 17,307 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chrousos Phaedra Director 2023-06-08 Grant or award +17,307 42,238 D
Derivatives
Chrousos Phaedra Director 2023-06-08 Grant or award · Stock Option (Right to Buy) +33,960 33,960 D
Loading xslF345X04/doc4.xml…